Periorbital cellulitis due to cutaneous anthrax

International Ophthalmology
Grant GillilandConnor Gilliland

Abstract

Virgil's plague of the ancient world, Bacillus anthracis, is rare in developed nations. Unfortunately rural communities across the globe continue to be exposed to this potentially lethal bacterium. Herein we report a case of periorbital cutaneous anthrax infection in a 3-year-old girl from the rural area surrounding Harare, Zimbabwe with a brief review of the literature.

References

Oct 1, 1989·The British Journal of Ophthalmology·D Yorston, A Foster
Jul 18, 2001·European Journal of Ophthalmology·S CelebiS Esmerligil
Jun 4, 2004·Japanese Journal of Ophthalmology·Ihsan CaçaAli Kemal KadiroGlu
Jun 5, 2007·Pediatric Dermatology·Hasibe ArtacIsmail Reisli
Jul 7, 2009·Molecular Aspects of Medicine·Maxime Schwartz
Sep 28, 2010·Journal of Infection and Public Health·Mehmet DoganayEmine Alp
Mar 16, 2011·FEMS Immunology and Medical Microbiology·Karen E BrennemanLeslie W Baillie
Sep 15, 2012·The Open Respiratory Medicine Journal·Carlos E KummerfeldtSteven A Sahn
Apr 10, 2013·Cutaneous and Ocular Toxicology·Recep TekinSaim Dayan
Dec 1, 2011·Asian Pacific Journal of Tropical Biomedicine·S M KamalM A Ahad

❮ Previous
Next ❯

Citations

Aug 20, 2015·Toxins·Christopher K Cote, Susan L Welkos
Dec 21, 2019·Revista Da Sociedade Brasileira De Medicina Tropical·Changsong ZhaoYao Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Related Papers

Igaku to seibutsugaku. Medicine and biology
R KawanaR Murakami
The New England Journal of Medicine
T C Gallagher, B E Strober
Nihon saikingaku zasshi. Japanese journal of bacteriology
Eiko Yabuuchi
PLoS Pathogens
Richard OkinakaPaul Keim
Clinical and Experimental Dermatology
A Taaffe, A Knight
© 2021 Meta ULC. All rights reserved